Current breast imaging modalities, advances, and impact on breast care.

Mammography will continue as the breast cancer screening imaging study of choice for the foreseeable future. Ultrasound and magnetic resonance imaging (MRI) are widely available adjunctive studies for women with suspicious mammographic or clinical findings, and MRI is a screening tool for women with specific increased risks for breast cancer. Options for diagnosis will continue to evolve and progress. This article discusses a wide variety of imaging options currently used and in development, their strengths, limitations, and potential future roles in the continuing pursuit of early breast cancer diagnosis, treatment, and follow-up.

[1]  Paolo Peterlongo,et al.  Prospective study of breast tomosynthesis as a triage to assessment in screening , 2012, Breast Cancer Research and Treatment.

[2]  S. Lundgren,et al.  Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. , 2000, Radiology.

[3]  Gisella Gennaro,et al.  Digital breast tomosynthesis versus digital mammography: a clinical performance study , 2010, European Radiology.

[4]  Mohan Doss,et al.  Positron Emission Mammography: Initial Clinical Results , 2003, Annals of Surgical Oncology.

[5]  Anders Tingberg,et al.  X-ray tomosynthesis: a review of its use for breast and chest imaging. , 2010, Radiation protection dosimetry.

[6]  S. Naganawa,et al.  Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging. , 2011, AJR. American journal of roentgenology.

[7]  Tomasz Opala,et al.  Factors influencing breast elasticity measured by the ultrasound Shear Wave elastography – preliminary results , 2011, Archives of medical science : AMS.

[8]  M. Nakano,et al.  Evaluation of Tumor Stiffness by Elastography Is Predictive for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer , 2012, Annals of Surgical Oncology.

[9]  Tim B. Hunter,et al.  Radiologic History Exhibit , 2000 .

[10]  D. Noh,et al.  Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases , 2011, Breast Cancer Research and Treatment.

[11]  David Gur,et al.  Dose reduction in digital breast tomosynthesis (DBT) screening using synthetically reconstructed projection images: an observer performance study. , 2012, Academic radiology.

[12]  J. Weigert,et al.  The Connecticut Experiment: The Role of Ultrasound in the Screening of Women With Dense Breasts , 2012, The breast journal.

[13]  Giuseppe Rescinito,et al.  One-to-one comparison between digital spot compression view and digital breast tomosynthesis , 2012, European Radiology.

[14]  Paul E Kinahan,et al.  The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements , 2008, Physics in medicine and biology.

[15]  R. Hendrick,et al.  Radiation doses and cancer risks from breast imaging studies. , 2010, Radiology.

[16]  R. Barr,et al.  Sonographic Breast Elastography , 2012, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[17]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Federica Zanca,et al.  Two-view and single-view tomosynthesis versus full-field digital mammography: high-resolution X-ray imaging observer study. , 2012, Radiology.

[19]  C. Merritt Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer , 2009 .

[20]  Matthew Zygmont BREAST IMAGING, 3RD EDITION, Daniel Kopans. Lippincott Williams & Wilkins (2006), 1136 pp, $249.00 , 2008 .

[21]  Mariko Goto,et al.  Microperfusion‐induced elevation of ADC is suppressed after contrast in breast carcinoma , 2009, Journal of magnetic resonance imaging : JMRI.

[22]  Elastography ultrasound and questionable breast lesions: does it count? , 2012, European journal of radiology.

[23]  David Gur,et al.  Digital breast tomosynthesis in the diagnostic environment: A subjective side-by-side review. , 2010, AJR. American journal of roentgenology.

[24]  C P Lawinski,et al.  A comparison of the accuracy of film-screen mammography, full-field digital mammography, and digital breast tomosynthesis. , 2012, Clinical radiology.

[25]  G. Sonmez,et al.  Value of diffusion-weighted MRI in the differentiation of benign and malign breast lesions , 2011, Wiener klinische Wochenschrift.

[26]  Andrew Smith,et al.  Full-field breast tomosynthesis. , 2005, Radiology management.

[27]  D LeBihan,et al.  Theoretical principles of perfusion imaging. Application to magnetic resonance imaging. , 1992 .

[28]  Jennifer A Harvey,et al.  Quantitative assessment of mammographic breast density: relationship with breast cancer risk. , 2004, Radiology.

[29]  E. Fishman,et al.  Tumor transport physiology: implications for imaging and imaging-guided therapy. , 2001, AJR. American journal of roentgenology.

[30]  Stanislaw Majewski,et al.  Dual-modality breast tomosynthesis. , 2010, Radiology.

[31]  L. Lanzkowsky,et al.  Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique. , 2012, AJR. American journal of roentgenology.

[32]  Paul Kinahan,et al.  Clinical Imaging Characteristics of the Positron Emission Mammography Camera: PEM Flex Solo II , 2009, Journal of Nuclear Medicine.

[33]  T. Bathen,et al.  Diffusion‐weighted and dynamic contrast‐enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients , 2011, Journal of magnetic resonance imaging : JMRI.

[34]  Woo Kyung Moon,et al.  Breast mass evaluation: factors influencing the quality of US elastography. , 2011, Radiology.

[35]  Hua Li,et al.  Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. , 2010, Medical physics.

[36]  L W Bassett,et al.  Highlights from the history of mammography. , 1990, Radiographics : a review publication of the Radiological Society of North America, Inc.

[37]  Selin Carkaci,et al.  Investigating the limit of detectability of a positron emission mammography device: a phantom study. , 2011, Medical physics.

[38]  Kim Thomson,et al.  Quantitative shear wave ultrasound elastography: initial experience in solid breast masses , 2010, Breast Cancer Research.

[39]  Deepa Narayanan,et al.  High‐Resolution Fluorodeoxyglucose Positron Emission Tomography with Compression (“Positron Emission Mammography”) is Highly Accurate in Depicting Primary Breast Cancer , 2006, The breast journal.

[40]  C. Gatsonis,et al.  Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.

[41]  Dieter Klatt,et al.  Evaluation of tomosynthesis elastography in a breast-mimicking phantom. , 2012, European journal of radiology.

[42]  Scintimammography in patients with minimal mammographic or clinical findings. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[43]  Ahmed S. Rahman,et al.  Effect of E-mail versus Postal Reminders for Mammogram Screening , 2006, AMIA.

[44]  C J Thompson,et al.  Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  R. Brem,et al.  Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade. , 2012, The British journal of radiology.

[46]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[47]  P. Sismondi,et al.  Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment. , 2007, Endocrine-related cancer.

[48]  Hui Zhi,et al.  Comparison of Ultrasound Elastography, Mammography, and Sonography in the Diagnosis of Solid Breast Lesions , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[49]  Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. , 2005, American journal of surgery.

[50]  D. Narayanan,et al.  Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. , 2011, Radiology.

[51]  Differential diagnosis of breast lesions using ultrasound elastography , 2011, The Indian journal of radiology & imaging.

[52]  C. Iacconi Diffusion and perfusion of the breast. , 2010, European journal of radiology.

[53]  Deepa Narayanan,et al.  Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  W. Svensson,et al.  Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses. , 2012, Radiology.

[55]  A. Thompson,et al.  Differentiating benign from malignant solid breast masses: value of shear wave elastography according to lesion stiffness combined with greyscale ultrasound according to BI-RADS classification , 2012, British Journal of Cancer.

[56]  A. Aravkin,et al.  Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG. , 2011, AJR. American journal of roentgenology.

[57]  Ying Yuan,et al.  Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis. , 2010, AJR. American journal of roentgenology.

[58]  Giuseppe Rescinito,et al.  Mammographic density estimation: one-to-one comparison of digital mammography and digital breast tomosynthesis using fully automated software , 2012, European Radiology.

[59]  Lubomir M. Hadjiiski,et al.  Digital breast tomosynthesis is comparable to mammographic spot views for mass characterization. , 2012, Radiology.

[60]  M. Espié,et al.  Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study , 2011, BMC Cancer.

[61]  Mark A Helvie,et al.  Digital mammography imaging: breast tomosynthesis and advanced applications. , 2010, Radiologic clinics of North America.

[62]  Christian Weismann,et al.  Breast Sonography – 2D, 3D, 4D Ultrasound or Elastography? , 2011, Breast Care.

[63]  J. Manson,et al.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. , 2010, JAMA.

[64]  T M Svahn,et al.  Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. , 2012, The British journal of radiology.

[65]  B. Garra,et al.  Elastography of breast lesions: initial clinical results. , 1997, Radiology.

[66]  Fernanda Philadelpho Arantes Pereira,et al.  Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. , 2009, AJR. American journal of roentgenology.

[67]  T. Matsumura,et al.  Breast disease: clinical application of US elastography for diagnosis. , 2006, Radiology.

[68]  Rachel F Brem,et al.  Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. , 2005, Radiology.

[69]  Marvin Zelen,et al.  Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms , 2009 .

[70]  Dana H Whaley,et al.  Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. , 2011, Radiology.

[71]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[72]  M. Plana,et al.  Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis , 2011, European Radiology.

[73]  Thomas E Yankeelov,et al.  Integration of diffusion‐weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy , 2011, Magnetic resonance in medicine.

[74]  M. Fink,et al.  Breast lesions: quantitative elastography with supersonic shear imaging--preliminary results. , 2010, Radiology.

[75]  David O. Cosgrove,et al.  Shear wave elastography for breast masses is highly reproducible , 2011, European Radiology.

[76]  E. Halpern,et al.  Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations. , 2005, Radiology.

[77]  R Luypaert,et al.  Quantification of perfusion and permeability in breast tumors with a deconvolution‐based analysis of second‐bolus T1‐DCE data , 2007, Journal of magnetic resonance imaging : JMRI.

[78]  Colleen H. Neal,et al.  Accuracy of quantitative ultrasound elastography for differentiation of malignant and benign breast abnormalities: a meta-analysis , 2012, Breast Cancer Research and Treatment.

[79]  D. Le Bihan,et al.  Magnetic resonance imaging of perfusion , 1990 .

[80]  O. Mawlawi,et al.  Evaluation of the quantitative accuracy of a commercially available positron emission mammography scanner. , 2011, Medical physics.

[81]  Rachel F Brem,et al.  Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. , 2008, Radiology.

[82]  D. Narayanan,et al.  Interpretation of positron emission mammography: feature analysis and rates of malignancy. , 2011, AJR. American journal of roentgenology.

[83]  P. Gordon Ultrasound for breast cancer screening and staging. , 2002, Radiologic clinics of North America.

[84]  Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors , 2012, Acta radiologica.

[85]  B. Moon,et al.  A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts , 2012, Annals of Nuclear Medicine.

[86]  W. Peng,et al.  Application of Breast Ultrasound in a Mammography-Based Chinese Breast Screening Study , 2012, Cell Biochemistry and Biophysics.

[87]  L. Tabár,et al.  Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.

[88]  Enzo Galligioni,et al.  Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. , 2008, European journal of cancer.

[89]  Sibel Kul,et al.  Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. , 2011, AJR. American journal of roentgenology.

[90]  Makoto Kojima,et al.  MR perfusion imaging using the arterial spin labeling technique for breast cancer , 2012, Journal of magnetic resonance imaging : JMRI.

[91]  Etta D Pisano,et al.  Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. , 2012, JAMA.

[92]  Unni Haakenaasen,et al.  Digital breast tomosynthesis (DBT): initial experience in a clinical setting , 2012, Acta radiologica.

[93]  D. Fraker,et al.  Breast carcinoma: MR imaging before re-excisional biopsy. , 1997, Radiology.

[94]  Pavel Y Stepanov,et al.  Positron Emission Mammography: High-Resolution Biochemical Breast Imaging , 2005, Technology in cancer research & treatment.

[95]  S. Boolbol,et al.  MRI Versus Breast-Specific Gamma Imaging (BSGI) in Newly Diagnosed Ductal Cell Carcinoma-in-situ: A Prospective Head-to-Head Trial , 2011, Annals of Surgical Oncology.

[96]  I. Mena,et al.  Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. , 1995, Radiology.

[97]  Wendy B DeMartini,et al.  Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. , 2009, AJR. American journal of roentgenology.

[98]  J. Baker,et al.  Breast tomosynthesis: state-of-the-art and review of the literature. , 2011, Academic radiology.

[99]  W. Han,et al.  Imaging sensitivity of dedicated positron emission mammography in relation to tumor size. , 2012, Breast.

[100]  A. Fausto,et al.  Clinical value of second-look ultrasound: is there a way to make it objective? , 2012, European journal of radiology.

[101]  P. Stomper,et al.  Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. , 1996, AJR. American journal of roentgenology.

[102]  U. Sharma,et al.  Longitudinal study of the assessment by MRI and diffusion‐weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy , 2009, NMR in biomedicine.

[103]  H. Nelson,et al.  Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[104]  W. Moon,et al.  Correlation of perfusion parameters on dynamic contrast‐enhanced MRI with prognostic factors and subtypes of breast cancers , 2012, Journal of magnetic resonance imaging : JMRI.

[105]  C. Gatsonis,et al.  MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. , 2007, The New England journal of medicine.

[106]  Wendy B DeMartini,et al.  Characterization of ductal carcinoma in situ on diffusion weighted breast MRI , 2011, European Radiology.

[107]  Nola M. Hylton,et al.  Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements. , 2011, Magnetic resonance imaging.

[108]  Wendy B DeMartini,et al.  Differential diagnosis of mammographically and clinically occult breast lesions on diffusion‐weighted MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[109]  David Gur,et al.  Digital breast tomosynthesis versus supplemental diagnostic mammographic views for evaluation of noncalcified breast lesions. , 2013, Radiology.

[110]  S. Majewski,et al.  The potential role of positron emission mammography for detection of breast cancer. A phantom study. , 2000, Medical physics.

[111]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[112]  Etta D Pisano,et al.  Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer. , 2012, AJR. American journal of roentgenology.

[113]  Ioannis Sechopoulos,et al.  Clinical digital breast tomosynthesis system: dosimetric characterization. , 2012, Radiology.

[114]  Anders Tingberg,et al.  Breast tomosynthesis: Accuracy of tumor measurement compared with digital mammography and ultrasonography , 2010, Acta radiologica.

[115]  B. Garra Imaging and Estimation of Tissue Elasticity by Ultrasound , 2007, Ultrasound quarterly.

[116]  David Gur,et al.  Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison. , 2011, AJR. American journal of roentgenology.

[117]  Javier Villanueva-Meyer,et al.  (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. , 2002, Radiology.

[118]  C. D'Orsi,et al.  Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.